
JPXHealthcareMedical - Devices
Latest quote
¥2,210
−¥27.00 · -1.21%
Eiken Chemical Co., Ltd. is a Japanese manufacturer and distributor specializing in clinical diagnostic products and medical equipment. The company excels in developing diagnostic solutions for diverse medical fields, encompassing biochemical analysis, immunology, serology, dry chemical assays, and automated diagnostic systems. A significant offering is the OC-SENSOR, an automated immunochemical fecal test designed to identify gastrointestinal bleeding linked to conditions such as colorectal cancer, polyps, and diverticulitis. Its comprehensive product portfolio further includes real-time turbidimeters, temperature-controlled equipment, various amplification and fluorescence detection reagents for research applications, and general detection kits. Eiken Chemical also produces a variety of microbiology-related products, alongside additional immunological and serological reagents. Established in Tokyo, Japan, in 1939, the company initially operated as Nihon Eiyokagaku Co., Ltd. until its rebranding to Eiken Chemical Co., Ltd. in 1969.
Latest quote
¥2,210
−¥27.00 · -1.21%
Regular session · JST · Market data may be delayed.
Eiken Chemical Co., Ltd. is a Japanese manufacturer and distributor specializing in clinical diagnostic products and medical equipment. The company excels in developing diagnostic solutions for diverse medical fields, encompassing biochemical analysis, immunology, serology, dry chemical assays, and automated diagnostic systems. A significant offering is the OC-SENSOR, an automated immunochemical fecal test designed to identify gastrointestinal bleeding linked to conditions such as colorectal cancer, polyps, and diverticulitis. Its comprehensive product portfolio further includes real-time turbidimeters, temperature-controlled equipment, various amplification and fluorescence detection reagents for research applications, and general detection kits. Eiken Chemical also produces a variety of microbiology-related products, alongside additional immunological and serological reagents. Established in Tokyo, Japan, in 1939, the company initially operated as Nihon Eiyokagaku Co., Ltd. until its rebranding to Eiken Chemical Co., Ltd. in 1969.
Day range
Current ¥2,210
52-week range
Current ¥2,210
Regular session · JST · Market data may be delayed.
Eiken Chemical Co., Ltd. is a Japanese manufacturer and distributor specializing in clinical diagnostic products and medical equipment. The company excels in developing diagnostic solutions for diverse medical fields, encompassing biochemical analysis, immunology, serology, dry chemical assays, and automated diagnostic systems. A significant offering is the OC-SENSOR, an automated immunochemical fecal test designed to identify gastrointestinal bleeding linked to conditions such as colorectal cancer, polyps, and diverticulitis. Its comprehensive product portfolio further includes real-time turbidimeters, temperature-controlled equipment, various amplification and fluorescence detection reagents for research applications, and general detection kits. Eiken Chemical also produces a variety of microbiology-related products, alongside additional immunological and serological reagents. Established in Tokyo, Japan, in 1939, the company initially operated as Nihon Eiyokagaku Co., Ltd. until its rebranding to Eiken Chemical Co., Ltd. in 1969.
Day range
Current ¥2,210
52-week range
Current ¥2,210
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 41.9B JPY | 40.54B JPY | 40.05B JPY | 43.27B JPY | 43B JPY |
| Cost of goods sold | 25.72B JPY | 24.03B JPY | 23.33B JPY | 22.77B JPY | 22.43B JPY |
| Gross profit | 16.18B JPY | 16.51B JPY | 16.72B JPY | 20.51B JPY | 20.57B JPY |
| Research and development | 3.68B JPY | 4.39B JPY | 3.94B JPY | 4.07B JPY | 3.41B JPY |
| Selling, general, and administrative | 9.58B JPY | 9.13B JPY | 9.41B JPY | 8.98B JPY | 8.78B JPY |
| Operating expenses | 13.26B JPY | 13.51B JPY | 13.35B JPY | 13.05B JPY | 12.18B JPY |
| Interest income | 17M JPY | 14M JPY | 8M JPY | 15M JPY | 18M JPY |
| Interest expense | 29M JPY | 17M JPY | 17M JPY | 16M JPY | 29M JPY |
| Depreciation and amortization | 2.54B JPY | 2.55B JPY | 2.33B JPY | 2.13B JPY | 2.06B JPY |
| Operating income | 2.92B JPY | 3B JPY | 3.38B JPY | 7.46B JPY | 8.39B JPY |
| Net income | 3.71B JPY | 2.23B JPY | 2.63B JPY | 5.74B JPY | 6.22B JPY |
Company facts updated Sep 11, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥56.00
2025 complete year+36.6% since 2021
2026 partial: ¥29.00
¥41.00
2,021
¥55.00
2,022
¥52.00
2,023
¥52.00
2,024
¥56.00
2,025
¥29.00
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 29, 2026 | ¥29.00Semi-Annual | Sep 30, 2026 | Sep 29, 2026 |
DividendUpcoming | Mar 31, 2027 | ¥29.00Semi-Annual | Mar 31, 2027 | Mar 31, 2027 |
Dividend | Mar 30, 2026 | ¥29.00Semi-Annual | Mar 31, 2026 | Jun 9, 2026 |
Dividend | Sep 29, 2025 | ¥29.00Semi-Annual | Sep 30, 2025 | Dec 1, 2025 |
Dividend | Mar 28, 2025 | ¥27.00Semi-Annual | Mar 31, 2025 | Jun 6, 2025 |
Dividend | Sep 27, 2024 | ¥26.00Semi-Annual | Sep 30, 2024 | Dec 2, 2024 |
Ex-dividend Sep 29, 2026
¥29.00
Semi-Annual
Record Sep 30, 2026 · Payment Sep 29, 2026
Ex-dividend Mar 31, 2027
¥29.00
Semi-Annual
Record Mar 31, 2027 · Payment Mar 31, 2027
Ex-dividend Mar 30, 2026
¥29.00
Semi-Annual
Record Mar 31, 2026 · Payment Jun 9, 2026
Ex-dividend Sep 29, 2025
¥29.00
Semi-Annual
Record Sep 30, 2025 · Payment Dec 1, 2025
Ex-dividend Mar 28, 2025
¥27.00
Semi-Annual
Record Mar 31, 2025 · Payment Jun 6, 2025
Ex-dividend Sep 27, 2024
¥26.00
Semi-Annual
Record Sep 30, 2024 · Payment Dec 2, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T166.03M0.01%2.92T JPY0.05%¥411.2-1.03%
Vanguard Total International Stock ETFVXUS5.97M0.00%646.2B USD0.05%$86.28-1.29%
Vanguard FTSE Developed Markets ETFVEA4.24M0.00%315B USD0.03%$71.92-1.24%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS1.62M0.01%13.6B USD0.06%$157.42-1.31%
WisdomTree Japan Hedged Equity FundDXJ1.45M0.02%6.99B USD0.48%$173.47+0.09%
Schwab International Small-Cap Equity ETFSCHC1.04M0.02%5.77B USD0.06%$50.40-1.49%
Vanguard FTSE Pacific ETFVPL456.36K0.00%13.1B USD0.07%$115.81-1.64%
Vanguard Total World Stock ETFVT384.37K0.00%97.9B USD0.06%$158.53-0.85%
iShares Core TOPIX ETF1475.T
Vanguard Total International Stock ETFVXUS
Vanguard FTSE Developed Markets ETFVEA
Vanguard FTSE All-World ex-US Small-Cap ETFVSS
WisdomTree Japan Hedged Equity FundDXJ
Schwab International Small-Cap Equity ETFSCHC
Vanguard FTSE Pacific ETFVPL
Vanguard Total World Stock ETFVTAI-generated and delayed market data for informational and educational purposes only. Not investment advice.